0
0
Loading version...
🔄 Update App
🔍 Check for Updates
Test Notification
🔔 Enable Notifications
📰 Fetch NHK News
🚀 Fetch TechCrunch News
🧪 Experiment
📰 Article Management
📚 Reading List
🎤 Speaking List
📊 Statistics
💻 Software Statistics
Push Admin
Edit Reading
Back to List
Basic Information
Title
Please enter a title.
URL
Please enter a valid URL.
Date
カテゴリID
画像ファイル名
統計情報
単語数:
126語
読了回数:
0回
作成日:
2022/08/14 21:26
更新日:
2025/12/09 14:20
本文
本文
Researchers in Japan say an antibody produced by infection with the Omicron subvariant BA.5 is less effective against a newer subvariant, BA.2.75. Professor Sato Kei of the Institute of Medical Science at the University of Tokyo heads the team of researchers, G2P-Japan. The findings of their study have not been formally peer-reviewed. The team used the blood of BA.5-infected hamsters to examine how the antibody works against the BA.2.75 subvariant. The researchers say the BA.5 antibody only had about one-12th of its potency when it was applied to the new subvariant. Sato noted that the BA.5 antibody may be less potent against the BA.2.75 subvariant. He added that if BA.2.75 continues to replace the prevalent BA.5 subvariant, the spread of infections may not be sufficiently curbed.
本文を入力してください。
メモ
メモ・感想
キャンセル
更新
Debug Info:
Saved State:
-
Redirected Flag:
-
Current URL:
-
Refresh
Close
Debug
Send Report
Send Report
Draw Arrow
Clear
Message:
Cancel
Send
